Kaye Randall

Track

Insider profile

Performance

Overall performance
1.0
Performance over holding periods
4.2
30 days 90 days 120 days
Average return -40% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
2 50% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -16%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Kaye Randall's trades of Longboard Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-10-16 2024-10-15
PlS Planned sale
251 +39.2%
434.87
US$1,442,163 		251 +39.2% 434.87 US$1,442,163
2024-09-16 2024-09-16
PrS Proposed sale
68,727
414.40
US$4,359,639 		68,727 414.40 US$4,359,639
2024-09-16 2024-09-16
PlS Planned sale
15,873 -15.8%
196.37
US$1,748,223 		15,873 -15.8% 196.37 US$1,748,223
2024-09-16 2024-09-16
PlS Planned sale
1,200 -5.7%
33.12
US$39,750 		1,200 -5.7% 33.12 US$39,750
2024-09-16 2024-09-16
PlS Planned sale
4,200 -16.7%
31.81
US$133,622 		4,200 -16.7% 31.81 US$133,622
2024-09-16 2024-09-16
PlS Planned sale
9,366 -27.1%
30.89
US$289,278 		9,366 -27.1% 30.89 US$289,278
2024-08-13 2024-08-12
PlS Planned sale
6,191 -25.7%
35.03
US$216,856 		6,191 -25.7% 35.03 US$216,856
2024-08-13 2024-08-12
PlS Planned sale
10,476 -30.3%
34.55
US$361,948 		10,476 -30.3% 34.55 US$361,948
2024-08-12 2024-08-12
PrS Proposed sale
16,667
35.09
US$584,845 		16,667 35.09 US$584,845
2024-08-13 2024-06-25
S Sale
100 -100.0%
20.87
US$2,087 		100 -100.0% 20.87 US$2,087
2024-08-13 2024-01-23
B Purchase
100 +inf%
24.82
US$2,482 		100 +inf% 24.82 US$2,482